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Sodium 4-phenylbutyrate protects against spinal
cord ischemia by inhibition of endoplasmic
reticulum stress
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Makoto Hamaishi, MD, Kenji Okada, MD, and Taijiro Sueda, PhD, Hiroshima, Japan
Objective: Delayed paraplegia after operation on the thoracoabdominal aorta is considered to be related to vulnerability
of motor neurons to ischemia. Previous studies have demonstrated the relationship between neuronal vulnerability and
endoplasmic reticulum (ER) stress after transient ischemia in the spinal cord. The aim of this study was to investigate
whether sodium 4-phenylbutyrate (PBA), a chemical chaperone that reduces the load of mutant or unfolded proteins
retained in the ER during cellular stress, can protect against ischemic spinal cord damage.
Methods: Spinal cord ischemia was induced in rabbits by direct aortic cross-clamping (below the renal artery and above the
bifurcation) for 15 minutes at normothermia. Group A (n  6) was a sham operation control group. In group B (n  6)
and group C (n 6), vehicle or 15 mg/kg/h of sodium 4-PBA was infused intravenously, respectively, from 30 minutes
before the induction of ischemia until 30 minutes after reperfusion. Neurologic function was assessed at 8 hours, and 2
and 7 days after reperfusion with a Tarlov score. Histologic changes were studied with hematoxylin-eosin staining.
Immunohistochemistry analysis for ER stress-related molecules, including caspase12 and GRP78 were examined.
Results: The mean Tarlov scores were 4.0 in every group at 8 hours, but were 4.0, 2.5, and 3.9 at 2 days; and 4.0, 0.7, and
4.0 at 7 days in groups A, B, and C, respectively. The numbers of intact motor neurons at 7 days after reperfusion were
47.4, 21.5, and 44.9 in groups A, B, and C, respectively. There was no significant difference in terms of viable neurons
between groups A and C. Caspase12 and GRP78 immunoreactivities were induced in motor neurons in group B, whereas
they were not observed in groups A and C.
Conclusion: Reduction in ER stress-induced spinal cord injury was achieved by the administration of 4-PBA. 4-PBA may
be a strong candidate for use as a therapeutic agent in the treatment of ischemic spinal cord injury. (J Vasc Surg 2010;
52:1580-6.)
Clinical Relevance: Spinal cord injury following surgical repair of thoracic or thoracoabdominal aorta is a disastrous
complication. Previous studies have demonstrated the relationship between neuronal vulnerability and endoplasmic reticulum
(ER) stress after transient ischemia of spinal cord. Sodium 4-phenylbutyrate (4-PBA) is a lowmolecular weight fatty acid that
has been approved for clinical use as an ammonia scavenger in childrenwith urea cycle disorders and for treatment of sickle cell
disease and thalassemia. A number of investigators have recently reported utilization of 4-PBA as a chemical chaperone to
reverse the mislocalization and/or aggregation of proteins associated with human disease. The 4-PBA of therapeutic dose has
low toxicity and uniquely penetrates well into cerebrospinal fluid. In this study, we investigated whether intravenous
administration of 4-PBA is beneficial to protecting the spinal cord against ischemic damage in a rabbit model. Spinal cord
ischemiawas induced by direct aortic cross-clampingwhile 4-PBAof therapeutic dosewas infused intravenously. In this simple
and less invasive model, reduction in ER stress-induced spinal cord damage was achieved by intravenous 4-PBA. Our results
indicate that 4-PBA of therapeutic dose can be a promising strategy, which is clinically feasible without significant adverse
effects. Although further investigations are mandatory before it is applied to the clinical practice, such as optimal timing or
route for administration 4-PBA, intravenous administration of 4-PBA may be a new candidate as a therapeutic agent for
protecting the spinal card against ischemic damage in thoracoabdominal aortic surgery.Paraplegia caused by ischemic spinal cord injury is one of
the most serious complications of surgery performed on the
thoracic and thoracoabdominal aorta, with a reported preva-
lence of 3% to 23% in different series.1-3 Various adjunctive
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1580procedures for spinal cord protection have been intro-
duced, including cerebrospinal fluid drainage, distal perfu-
sion of the aorta, or use of steroid, barbiturate, or free-radical
scavengers, and have successfully reduced the incidence of
postoperative paraplegia in recent years. However, postop-
erative paraplegia remains a devastating complication, and
its occurrence is still somewhat unpredictable. Patients
undergoing thoracic aneurysm repair who awake without
neurologic deficit immediately after the operation may
eventually develop paraplegia.4,5 The exact mechanism of
such a delayed vulnerability is not fully understood. In a
rabbit spinal cord ischemia model, delayed and selective
motor neuron death after transient ischemia has been re-
ported, and it was greatly associated with activated apopto-
tic signals.6
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apoptosis is initiated by cell-surface receptors or by mito-
chondrial stress.7 Recently, another apoptotic-regulatory
pathway involved in endoplasmic reticulum (ER) stress has
received attention. In the case of mild ER stress, cells
develop a self-protective, signal transduction pathway
termed the unfolded protein response, which includes in-
duction of molecular chaperones in the ER such as glucose
regulated protein 78 (GRP78), translational attenuation,
and ER-associated protein degradation.8,9 However, if the
damage is severe, the unfolded protein response ultimately
triggers the apoptosis pathway.10 One of the important
molecules relevant to cell death is caspase12 which is re-
garded to be a representative cell death signal in ER
stress.11 Sodium 4-phenylbutyrate (4-PBA) is a low mo-
lecular weight fatty acid that has been approved for
clinical use as an ammonia scavenger in children with
urea cycle disorders and for treatment of sickle cell
disease and thalassemia on the basis of its capacity to
activate transcription of - and -globin.12,13 4-PBA has
been found to prolong life and contribute to therapy for
spinal muscular atrophy by altering the pattern of gene
expression. In the last few years, a number of studies have
described the use of 4-PBA as a chemical chaperone to
reverse the mislocalization and/or aggregation of pro-
teins associated with human disease. 4-PBA can act as a
chemical chaperone by reducing the load of mutant or
mislocated proteins retained in the ER.14-16 Evidence
obtained in recent years has demonstrated that endoplas-
mic reticulum (ER)-mediated cell death plays an impor-
tant role in the mechanisms underlying ischemia-reper-
fusion neuronal damage. Therefore, targeting the ER
may provide a therapeutic approach for blocking the
pathologic process induced by spinal cord ischemia.
However, to our knowledge, no pharmacologic ap-
proach for treating spinal cord ischemia-induced ER
dysfunction has been reported. In this study, we investi-
gated the protective effects of 4-PBA after transient
spinal cord ischemia, apoptotic signaling of caspase12,
and induction of GRP78.
MATERIALS AND METHODS
Animal preparation. Animal care and all procedures
were performed in compliance with the Guide for the Care
and Use of Laboratory Animals prepared by the Institute of
Laboratory Animal Resources, National Research Council,
and published by the National Academy Press, revised
1996. This study protocol was approved by the Research
Facilities for Laboratory Animal Science of the Hiroshima
University School of Medicine.
Anesthesia and monitoring. We used Japanese fe-
male white rabbits (2.5-3.0 kg) in this experiment. General
anesthesia was induced with an intramuscular injection of
ketamine 50 mg/kg. An ear vein catheter was inserted for
the continuous intravenous infusion of lactated Ringer
solution. Cefazolin (10 mg/kg) was injected through the
catheter. After a tracheostomy and endotracheal intuba-
tion, the rabbits were ventilated mechanically with a frac-tion of inspired oxygen of 1.0 and isoflurane (1.5%-2.0%)
to induce sufficient anesthesia. Adequacy of ventilation was
monitored by blood gas analysis. The arterial blood pres-
sure was measured by a catheter (JMS cut-down tube; C3,
Hiroshima, Japan) placed into the right femoral artery.
Electrocardiogram was also monitored continuously. The
operation was performed at normothermia. The rectal tem-
perature was continuously monitored and kept at 38.0 
0.5°C during the operation using a heating blanket.
Surgical procedures. With animals in the right lateral
decubitus position, a flank skin incision parallel to the spine
was made on the left side. From a retroperitoneal approach,
the abdominal aorta was exposed below the left renal artery
and above the iliac bifurcation, and was encircled. After the
intravenous administration of heparin (100 U/kg), the
abdominal aorta just distal to the left renal artery and just
proximal to the iliac bifurcation was cross-clamped and
isolated for 15 minutes to produce spinal cord ischemia. To
determine the clamping time, we conducted preliminary
experiments. Fifteen rabbits were divided into three groups
with clamping times of 10, 12, and 15 minutes (n  5 for
each group). Only the abdominal aorta just distal to the left
renal artery was clamped. At 7 days after reperfusion, the
groups clamped for 15 minutes were all paraplegic.
For the formal experiments, female domesticated white
rabbits, weighing 2.5 to 3.0 kg, were divided into three
groups: sham operation control group (group A, with only
aortic exposure but without transient ischemia), transient
ischemia and treatment with vehicle group (group B), and
transient ischemia and treatment with 4-PBA group (15
mg/kg/h, group C). Saline solution (vehicle, 1 mL/kg
body weight) or 4-PBA (4 mg/mL in saline vehicle) was
administered intravenously from 30 minutes before induc-
tion of ischemia until 30 minutes after reperfusion. Total
operation time ranged from 1.5 hours to 2.5 hours, and the
total amount of 4-PBA administration ranged from 46.9
mg to 56.3 mg. After 15 minutes, the aortic clamp was
removed. The abdomen was closed, and all catheters were
withdrawn. The animals were allowed to recover from
anesthesia and extubated, and routine postoperative care
was carried out. Immediately after euthanasia, the spinal cord
was quickly removed through a laminectomy at L4 and the
bone around the spinal cord was chopped off. All samples
were frozen in powdered dry ice and stored at80°C.
Neurologic and histopathologic studies. The neu-
rologic status in groups A, B, and C (n  6 in each group)
was assessed at 8 hours, and 2 and 7 days after reperfusion
by an observer blinded to the protocol used for each
animal. The motor function of the hind limbs was graded
by using the Tarlov score, in which 0 indicates no move-
ment of the hind limbs, 1 indicates perceptible movement
of the joints of the hind limbs, 2 indicates good movement
of the joints but an inability to stand, 3 indicates the ability
to stand and walk, and 4 indicates a complete recovery.17
The animals (n  6 in each group) were then euthanized
after the completion of the neurologic evaluation at 7 days.
Sectioned specimens from the lumbar spinal cord at the L4
level were stained with hematoxylin and eosin and were
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microscopy. Neuronal ischemic injury was evaluated at a
magnification of200 by an observer blinded to the treat-
ment groups. Normal motor neurons in the anterior horn
of the spinal cord (anterior to a line drawn through the
central canal perpendicular to the anterior median fissure)
were counted for each animal and averaged. Ischemic neu-
rons were defined by the following criteria: (1) shrinkage of
the cell body, (2) an eosinophilic cytoplasm with a loss of
Nissl granules, (3) triangular and pyknotic nuclei, and (4) a
homogenizing change of the neuron.
Caspase12 and GRP78 immunohistochemistry.
Immunohistochemistry was used to evaluate the changes in
expression of caspase12 and GRP78, at 8 hours and 1 day
after reperfusion in groups A, B, and C (n  3 for each
group at each time point). After endogenous peroxidase
activity was quenched by exposing the slides to 0.3% H2O2
and 10% methanol for 30 minutes, the spinal cord sections
were blocked in 2% normal horse serum for 2 hours at room
temperature. Next, they were incubated with primary anti-
bodies for 20 hours at 4°C. The primary antibodies used
were as follows: rat monoclonal anti-caspase12 antibody
(SC-12747; Santa Cruz Biotechnology Inc, Santa Cruz,
Calif) diluted 1:50 and goat polyclonal anti-GRP78 anti-
body (SC-1050; Santa Cruz Biotechnology) diluted 1:200.
The slides were rinsed in PBS and incubated for 3 hours
with biotinylated antirat IgG (PK-6104; Vector Laborato-
ries, Burlingame, Calif) and biotinylated antigoat IgG (PK-
6105; Vector Laboratories) at 1:200 dilution in PBS contain-
ing 0.018% normal horse serum, respectively. Subsequently,
they were incubated with avidin-biotin-horseradish per-
oxidase complex (PK-6104 and PK-6105). The slices
were colonized with DAB/H2O2 solution and cyto-
plasm, and counterstained with hematoxylin. To ascer-
tain specific binding of antibody for protein, a set of
sections were stained in a similar way without primary
antibody.
Statistical analysis. All results were expressed as
means  SD. Statistical significance was assumed at a P
value of.05. TheMann-WhitneyU test, one-way analysis
of variance, and post hoc tests with the Fisher protected
least significant difference test were used to adequately
identify which group differences accounted for the signifi-
cant P value.
RESULTS
Physiologic status. There were no significant changes
in the distal mean arterial pressures and heart rates between
the groups during the operation. All 18 animals survived
for 7 days without significant intra- or postoperative com-
plications.
Neurologic outcomes. Fig 1 shows the neurologic
outcomes of rabbits in each group. The Tarlov scores in
groups A, B, and C were 4.0  0.0, 4.0  0.0, and 4.0 
0.0 at 8 hours; 4.0  0.0, 2.5  1.2, and 3.9  0.4 at 2
days; and 4.0 0.0, 0.7 0.8, and 4.0 0.0 at 7 days after
reperfusion, respectively. While all sham-operated control
animals (group A) demonstrated normal neurologic func-tion, the group B rabbits presented with progressive dete-
rioration of neurologic function, as was anticipated from
the results of the preliminary experiments. Five out of six
rabbits in group B demonstrated severe paraparesis by 7
days. In group C, neurologic function slightly deteriorated
at 2 days but recovered by 7 days. There was no significant
difference in Tarlov score between groups A and C across
all time points. The score was significantly higher in group
C than in group B at 2 and 7 days (P  .0001).
Histopathologic assessment. Fig 2 shows the typical
histopathologic findings of the spinal cord from a group B
rabbit with paraplegia and a group C rabbit with normal
neurologic function in comparison with those in group A.
In group B (Fig 2, B), the motor neurons in the anterior
horn were shrunken or had pale homogenous cytoplasm
compared with those in group A, consistent with ischemic
change. In group C (Fig 2, C), no apparent histologic
changes were detected. The number of motor neurons with
a normal appearance in the anterior horn of the spinal cord
at 7 days after reperfusion was 47.4 5.7, 21.5 6.0, and
44.9 7.9 in groups A, B, and C, respectively (Fig 3). The
number of normal neurons was significantly less in group B
than in groups A and C (P  .0001). There was no
significant difference in the number of normal neurons
between groups A and C (P  .019).
Histochemical study. Immunohistochemistry results
for caspase12 and GRP78 are shown in Figs 4 and 5. In the
sham-operated animals, there was no evidence of caspase12
and GRP78 expression in any cells of the spinal cord. In
group B, caspase12 and GRP78 were present in motor
neurons after 8 hours of reperfusion (Fig 4,A and Fig 5,A)
but were apparently reduced at 1 day (Fig 4, B and Fig 5,
B). In group C, expression of caspase12 and GRP78 in
motor neurons was not observed at either 8 hours or 1 day
(Fig 4, C and D, and Fig 5, C and D).
DISCUSSION
This study has demonstrated that the peripheral admin-
Fig 1. Changes in Tarlov score at 8 hours, and 2 and 7 days
after reperfusion. In groups A and C, the Tarlov score was
significantly higher at 2 and 7 days than in group B (*P  .002,
**P .0001). There was no significant difference in neurologic
function between groups A and C.istration of 4-PBA at therapeutic doses prevents both im-
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following an ischemic insult. Neurologic function was pre-
served with little histologic change observed in motor
neurons, most probably due to suppression of ER stress.
When cells are exposed to stress, ER function is dis-
rupted. Because the ER regulates the folding and quality
control systems of membrane and secretory proteins, ER
stress leads to an accumulation of unfolded proteins in the
ER lumen and ER-mediated cell death can be induced.18 In
ER stress, several signaling pathways from the ER such as
the unfolded protein response (UPR) are simultaneously
activated. Accumulation of unfolded proteins in the ER is
Fig 2. Histologic findings of spinal cord 7 days after 15 minutes
of ischemia (hematoxylin and eosin staining). A, Sham-operated
control spinal cord was intact. B, In spinal cord of group B, about
60% of motor neurons were lost. C, In group C, no ischemic
damage was detected, and there were many normal motor
neurons.sensed by inositol-requiring protein 1 (IRE1), a serine/threonine kinase with an endoribonuclease domain in the
ER membrane, and transcription induction of chaperone
genes such as glucose-regulated proteins (GRPs) including
GRP78 is promoted to re-fold the unfolded and accu-
mulated proteins.19,20 Caspase12, the first identified
ER-associated member of the caspase family, is regarded
as a representative molecule implicated in the cell death-
pathway seen in ER stress.11
ER stress has been reported to contribute to ischemia-
reperfusion injury in the brain and spinal cord by inducing
apoptosis of neuronal cells.8,10,21,22 We speculated that
targeting the ER-associated apoptotic pathway might be an
effective way to minimize neuronal cell damage, and ex-
plored the effect of an ER stress inhibitor, 4-PBA, on
minimizing the ischemic injury using a rabbit spinal cord
ischemia model.
A low molecular weight fatty acid, 4-PBA, can act as a
chemical chaperone, assisting with protein folding and thus
relieving the ER stress of the cell.16,23-25 In the present
study, 4-PBA administration was associated with decreased
expression of caspase12 and GRP78 as well as the number
of apoptotic cells, suggesting it has beneficial effects on
attenuating ER stress. It appears to effectively reduce the
neuronal damage, which progresses after reperfusion.
Treatment with 4-PBA 30 minutes before and after isch-
emia notably improved the neurologic outcome. We used
the 4-PBA dose of 15 mg/kg/h, based on phase 1 and
pharmacokinetic studies of 4-PBA by peripheral infu-
sion.26,27 It has low toxicity and good penetrations into the
cerebrospinal fluid.28 It has been clinically used for treat-
ment of urea cycle disorders in children, sickle cell disease,
thalassemia, and cystic fibrosis.29 Our study has suggested
that 4-PBA at therapeutic doses can be a potential agent for
preventing spinal cord ischemia. We found that 4-PBA
seems to widely suppress ER stress-mediated apoptotic
signaling under conditions of ischemia. Considering the
findings of the present study, it is reasonable to conclude
that the protective effect of 4-PBA on ER stress-mediated
Fig 3. The number of viable neurons in the gray matter of lumbar
spinal cord sections stained with hematoxylin and eosin. Group C
had significantly more viable neurons than group B (P  .0001
compared with group B).injury may involve the activity of chemical chaperone.
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emia: immediate and delayed.30 The former is often caused
by a severe ischemic insult and rapidly leads to necrotic
neuronal cells. The latter is caused either by apoptosis6,31,32
or necrosis.30,33,34 Disruption of the infrarenal abdominal
aortic blood flow for 15 minutes causes immediate neuro-
nal injury by 2 days and delayed paraplegia by 7 days.6,31-34
In the current study, 4-PBA prevented not only immediate
neuronal injury but also delayed paraplegia. In the 4-PBA-
treated groups, many intact motor neurons were preserved,
whereas in the negative control group, the immunohisto-
chemical findings showed expression of caspase12 in motor
neurons. To date, 14 caspases have been discovered. They
are supposed to be activated in a multiple cascade fashion,
activated by caspase9,35 an initiator caspase. Under appro-
priate stress signals, caspase12 is not only activated within
the ER but also translocates to the cytosol, where it can
activate caspase9 in a noncytochrome-c–dependent man-
ner.36 Activation of caspase 12 is considered to be one of
the potential mechanisms by which the ER contributes to
apoptosis. Expression of caspase12 precedes the appearance
of neuronal damage and might, therefore, be implicated in
the activation of apoptosis.
There are a few points to consider when 4-PBA is
Fig 4. Immunohistochemical staining for caspase12 in
hours (C) and 1 day (D) in group C. Density of caspase
in group B (black arrows).applied to clinical situation. First, histologic examinationshows that there is some loss of motor neurons in the
4-PBA-treated groups, indicating that the protective effect
of 4-PBA is not perfect. One strategy that may enhance the
effectiveness of 4-PBA without increasing its adverse effects
is topical injection into the clamped segment of the aorta or
combined use of 4-PBA with topical/core cooling. Al-
though preservation of the feeding artery to the spinal cord
is essential, such an artery cannot always be identified
preoperatively. The protective effect of 4-PBA adminis-
tered intravenously or the above-mentioned integrated
“spinoplegia” protocol may be a potential option in such
instances.
Second, the spinal cord anatomy and circulation in
rabbits differ significantly from humans. The main source
of blood in the rabbit spinal cord is a segmental supply from
the abdominal aorta.37 Thus, the lumbar spinal cord of
rabbits becomes ischemic by clamping of the infrarenal
aorta. Despite the different anatomy, rabbits are often used
as the experimental model of spinal cord ischemia because
of the simplicity and reproducibility of the model. Some
studies have occluded the infrarenal aorta with an intra-
aortic balloon.6,31,32 Although this procedure is easy and
less invasive, it is unclear whether aortic occlusion is com-
plete or not. We chose a direct clamping of the aorta
cords at 8 hours (A) and 1 day (B) in group B, and at 8
munoreactivity in group C was reduced relative to thatspinal
12 imthrough a retroperitoneal approach to precisely determine
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development of paraplegia. On this basis, the current study
showed the beneficial effect of 4-PBA.
Third, the drug toxicity of intravenous administration of
4-PBA and the peak time of ER stress at the onset of ischemia
are other concerns that will likely limit the clinical application
of 4-PBA, although reported side effects are not consider-
able.26 An additional experiment that examines the timing of
injection, injection method and dosage of 4-PBA administra-
tion would be required before any clinical applications.
In conclusion, administration of 4-PBA intravenously
is feasible and effective without apparent neuronal damage
of the spinal cord in a rabbit model. This study indicated
that this method can potentially be a useful adjunct for
spinal cord protection during thoracic and thoracoabdomi-
nal aortic operations.
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